InMode (INMD) Shares Outstanding (2018 - 2026)
InMode (INMD) posted quarterly Shares Outstanding (Entity) of $63401.0 for Q1 2026, down 7.79% year-on-year from $68760.0 in Q1 2025, and down 99.9% on a QoQ basis from $63.4 million in Q4 2025.
InMode (INMD) Shares Outstanding (2018 - 2026) Analysis & Trends
InMode (INMD) has reported Shares Outstanding (Entity) for 9 consecutive years, with $63401.0 the latest figure, recorded in Q1 2026.
- Quarterly Shares Outstanding (Entity) fell 7.79% year-over-year to $63401.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $63401.0 (down 7.79% YoY) and the FY2025 annual result came in at $63.4 million, down 8.91% from the prior year.
- Shares Outstanding (Entity) declined to $63401.0 in Q1 2026 per INMD's latest filing, from $63.4 million in the prior quarter.
- Over the last five years, Shares Outstanding (Entity) for INMD reached as high as $84.0 million in Q4 2023 and fell as low as $63401.0 in Q1 2026.
- A 5-year average of $17.7 million and a median of $83154.0 in 2023 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) grew 6.3% — and 2025, when it fell 21.64%.
- Year by year, Shares Outstanding (Entity) stood at $82.5 million in 2022, then climbed by 1.74% to $84.0 million in 2023, then declined by 17.17% to $69.6 million in 2024, then dropped by 8.91% to $63.4 million in 2025, then slumped by 99.9% to $63401.0 in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $63401.0, $63.4 million, and $65072.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 385.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 951.57 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 867.00 Mn |
| 10 | InMode | 956,721.10 | -479.17 Mn | 61.55 Mn | 63,401.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63,401.00 |
| Dec 31, 2025 | 64.63 Mn |
| Sep 30, 2025 | 65,072.00 |
| Jun 30, 2025 | 65,982.00 |
| Mar 31, 2025 | 68,760.00 |
| Dec 31, 2024 | 79.31 Mn |
| Sep 30, 2024 | 81,795.00 |
| Jun 30, 2024 | 84,205.00 |
| Mar 31, 2024 | 84,523.00 |
| Dec 31, 2023 | 83.53 Mn |
| Sep 30, 2023 | 83,423.00 |
| Jun 30, 2023 | 83,405.00 |
| Mar 31, 2023 | 83,154.00 |
| Dec 31, 2022 | 82.48 Mn |
| Sep 30, 2022 | 82,494.00 |
| Jun 30, 2022 | 82,590.00 |
| Mar 31, 2022 | 82,973.00 |
| Dec 31, 2021 | 81.44 Mn |
| Sep 30, 2021 | 80,843.00 |
| Jun 30, 2021 | 81,700.00 |